We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IGSB icon
251
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$50.9M 0.07%
952,540
-7,836
-0.8% -$414K
TRGP icon
252
Targa Resources
TRGP
$55.1B
$50.5M 0.07%
1,285,860
-24,674
-2% -$980K
AMLP icon
253
Alerian MLP ETF
AMLP
$12.8B
$49.9M 0.07%
1,013,168
-49,288
-5% -$2.44M
LLY icon
254
Eli Lilly
LLY
$1.06T
$49.9M 0.07%
450,365
-64,977
-13% -$7.65M
PTLC icon
255
Pacer Trendpilot US Large Cap ETF
PTLC
$3.38B
$49.6M 0.07%
1,621,392
+498,813
+44% +$14.9M
TSM icon
256
TSMC
TSM
$2.18T
$49.4M 0.07%
1,262,202
+2,285
+0.2% +$94.1K
PPG icon
257
PPG Industries
PPG
$26.6B
$49.4M 0.07%
423,493
+14,144
+3% +$1.61M
IONS icon
258
Ionis Pharmaceuticals
IONS
$9.4B
$49.4M 0.07%
768,960
-26,357
-3% -$1.86M
EVRG icon
259
Evergy
EVRG
$19.2B
$49.2M 0.07%
818,503
-13,747
-2% -$804K
SHY icon
260
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
$48.6M 0.07%
573,401
+111,330
+24% +$9.38M
SLB icon
261
SLB Ltd
SLB
$75B
$48.6M 0.07%
1,222,986
-178,358
-13% -$7.19M
NSC icon
262
Norfolk Southern
NSC
$75.1B
$48.1M 0.07%
241,210
-3,428
-1% -$680K
FNF icon
263
Fidelity National Financial
FNF
$13.5B
$48M 0.07%
1,239,389
+976,219
+371% +$36.8M
SRE icon
264
Sempra
SRE
$54.8B
$47.7M 0.07%
693,750
+25,338
+4% +$1.66M
HEI.A icon
265
HEICO Corp Class A
HEI.A
$37.2B
$47.6M 0.07%
460,955
-51,345
-10% -$4.73M
FDX icon
266
FedEx
FDX
$75.4B
$47.3M 0.07%
288,229
+25,875
+10% +$4.53M
XLF icon
267
State Street Financial Select Sector SPDR ETF
XLF
$58.2B
$47.1M 0.07%
1,707,614
-47,868
-3% -$1.3M
AEP icon
268
American Electric Power
AEP
$68.4B
$47M 0.07%
534,241
-265,208
-33% -$22.9M
DEO icon
269
Diageo
DEO
$53.6B
$46.9M 0.07%
272,012
+2,808
+1% +$472K
FV icon
270
First Trust Dorsey Wright Focus 5 ETF
FV
$3.77B
$46.8M 0.07%
1,539,853
-204,230
-12% -$6.11M
IWO icon
271
iShares Russell 2000 Growth ETF
IWO
$15.1B
$46.4M 0.07%
230,865
+657
+0.3% +$130K
RSG icon
272
Republic Services
RSG
$65.7B
$46.2M 0.07%
532,850
+19,905
+4% +$1.66M
DVY icon
273
iShares Select Dividend ETF
DVY
$23.6B
$46M 0.07%
462,416
+6,641
+1% +$655K
SYF icon
274
Synchrony
SYF
$25.6B
$45.9M 0.07%
1,325,222
+50,003
+4% +$1.69M
UMPQ
275
DELISTED
Umpqua Holdings Corp
UMPQ
$45.6M 0.07%
2,745,977
-147,555
-5% -$2.49M

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.